Mesoblast (MEOBF) Payables (2015 - 2026)

Mesoblast has disclosed Payables across 12 years of filings, most recently posting $46.8 million for Q2 2026.

• In Q2 2026, Payables rose 145.29% year-over-year to $46.8 million; the TTM figure through Jun 2026 stood at $46.8 million (up 145.29% YoY), while the FY2026 annual figure was $46.8 million, up 145.29% from the prior year.
• Payables came in at $46.8 million for Q2 2026 at Mesoblast, up from $33.6 million in the prior quarter.
• In the past five years, Payables ranged from a high of $46.8 million in Q2 2026 to a low of $7.1 million in Q2 2024.
• Average Payables over 5 years is $21.1 million, with a median of $19.6 million recorded in 2023.
• Year-over-year, Payables tumbled 64.9% in 2024 and surged 183.1% in 2025.
• Over 5 years, Payables stood at $23.0 million in 2022, then tumbled by 53.2% to $10.8 million in 2023, then advanced by 10.22% to $11.9 million in 2024, then surged by 183.1% to $33.6 million in 2025, then soared by 39.4% to $46.8 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $46.8 million in Q2 2026, $33.6 million in Q4 2025, and $19.1 million in Q2 2025.